Global venture capital firm with a focus on early and growth-stage technology companies.
Verified emails & LinkedIn for founders across this portfolio.
Captor Therapeutics is a bio-pharmaceutical firm focused on development of protein degradation drugs for cancer and autoimmune diseases.
Arkadia Space provides design, develop and commercialise engines and propulsion systems based on green propellants; the best alternative.
Molecular Attraction is a bio-attractant discovery company.
Transforming chronic wound care with breakthrough enzymatic technology
Pixel Photonics manufactures scalable single-photon detectors for applications like secure quantum communication.
Zero Point Motion develops inertial sensors to enable precision positioning and navigation.
RAYDIAX is a manufacturing company which makes therapy-assist CT systems that enable minimally invasive interventions.
Gen AI Last - Your Content Creation Tool Powered By Artificial Intelligence And Machine Learning
Vexlum Provider of high-brightness semiconductor laser technology.
Gedea Biotech develops an antibiotic-free, safe and effective treatment of vaginal fungal infections.
Cellfion provides sustainable materials for next level clean energy storage and conversion devices.
Hyme Energy develops systems to provide low-carbon industrial heat using molten salt energy storage technology.
Silk-fibroin tissue engineering technology platform
Delox is designing and developing a new generation of bio-decontamination devices.
HAWK Biosystems is a cancer diagnostics platform.
FluIDect develops real-time, on-site pathogen detection devices, bringing lab analytics to production lines for real-time results.
Novobiom specializes in unblocking the power of fungi to revolutionize waste management and build a sustainable future.
UniSCool is an IT consulting firm that offers energy efficiency, sustainability, heat transfer, and thermal management services.
Oxolife is a biotechnology company in the clinical phase of development.
Iktos is a deep learning technology platform focused on new drug design and discovery.
Vivalyx is committed to saving the lives of organ failure patients by boosting the vitality and number of donor organs.
AptaTargets is a biopharmaceutical company focused in developing therapeutic
SEMRON develops a 3D-scaled AI inference chip, based on a new proven semiconductor device.
N-Ink provides n-type ink which is compatible with Printed Electronics, the Internet of Things, and Bioelectronics.
EIC Accelerator has invested in 338 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
EIC Accelerator's top investment sectors include Biotechnology, Health Care, Medical, Manufacturing, Biopharma. The firm invests across 40 different industry categories.
Among tracked funding rounds, Captor Therapeutics received $17.7M in a Post-IPO Equity round. EIC Accelerator's total known invested capital is $1.7B.
EIC Accelerator's average investment size is $6.0M across its portfolio of 338 companies.
Recent EIC Accelerator portfolio additions include Captor Therapeutics, Arkadia Space, Molecular Attraction, SolasCure, Pixel Photonics. These companies were founded in 2020 or later.